gene

CX3CL1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CX3CL1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

489Connections
4Hypotheses
5Analyses
50Outgoing
50Incoming
0Experiments
9Debates

Summary

Page for CX3CL1 — Fractalkine (C-X3-C Motif Chemokine Ligand 1)

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolCX3CL1
Full NameFractalkine (C-X3-C Motif Chemokine Ligand 1)
AliasesC-X3-C Motif Chemokine Ligand 1
Chromosome16q13
Primary ExpressionNeurons (cortex, hippocampus), Endothelial cells, Dendritic cells
Amino Acids373 aa
PathwaysNeuroinflammatory
UniProt IDP78423
NCBI Gene ID6376
Ensembl IDENSG00000006210
OMIM601880
GeneCardsCX3CL1
Human Protein AtlasCX3CL1
Associated DiseasesAls, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis
InteractionsAGING, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMPK, AMYLOID
KG Connections484 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: CX3CL1 — AlphaFold P78423 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (3)

Knowledge base pages for this entity

Canonical Page

Fractalkine (CX3CL1) - Neuroinflammation Biomarker

biomarker · 2458 words

CX3CL1 (Fractalkine) Protein

protein · 1815 words

CX3CL1 — Fractalkine (C-X3-C Motif Chemokine Ligand 1)

gene · 1391 words

Pathway Diagram

graph TD
    CX3CL1["CX3CL1"]
    CX3CL1 -->|"expressed in"| Neurodegeneration["Neurodegeneration"]
    CX3CL1 -->|"regulates"| Inflammation["Inflammation"]
    CX3CL1 -->|"regulates"| Neuroinflammation["Neuroinflammation"]
    CX3CL1 -->|"target for"| Aging["Aging"]
    CX3CL1 -->|"interacts"| Ms["Ms"]
    CX3CL1 -.biomarker for.-> Senescence["Senescence"]
    CX3CL1 -.biomarker for.-> Als["Als"]
    CX3CL1 -.biomarker for.-> Longevity["Longevity"]
    CX3CR1["CX3CR1"] -->|"target for"| CX3CL1
    FGF21["FGF21"] -->|"activates"| CX3CL1
    APP["APP"] -.biomarker for.-> CX3CL1
    FNDC5["FNDC5"] -->|"activates"| CX3CL1
    S100B["S100B"] -.biomarker for.-> CX3CL1
    PLAU["PLAU"] -->|"activates"| CX3CL1
    CXCL10["CXCL10"] -->|"activates"| CX3CL1
    C1Q["C1Q"] -.biomarker for.-> CX3CL1
    OVERVIEW["OVERVIEW"] -->|"expressed in"| CX3CL1
    FGF23["FGF23"] -->|"activates"| CX3CL1

Outgoing (341)

TargetRelationTypeStr
Neuronsinteracts_withcell_type0.95
Fractalkineassociated_withprotein0.95
Frailtybiomarker_forphenotype0.95
Cx3Cr1bindsprotein0.95
Neuroinflammationmodulatesprocess0.95

Incoming (148)

SourceRelationTypeStr
Repetitive Transcranial Magnetic Stimulationupregulatesdrug0.92
GABAergic Neuronproducescell_type0.90
h-494861d2targetshypothesis0.90
miR-16-5pdownregulatesbiomarker0.85
miR-125b-5pdownregulatesbiomarker0.85

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
GluN2B-CX3CL1 Axis Controls Microglial Tau Phagocytosis 0.761 neuroscience GluN2B-Mediated Thalamocortical Control
CX3CL1-CX3CR1 Mimetic Therapy for Neuroprotection 0.635 neurodegeneration Microglial subtypes in neurodegeneration
Soluble CX3CL1 cleavage by ADAM proteases disengages fractal 0.540 neurodegeneration Synaptic pruning by microglia in neurode
CX3CL1 Mimetic Peptide to Disrupt Fractalkine Signaling Dysr 0.459 immunomics Systemic immune profiling in neurodegene

Mentioning Analyses (5)

Scientific analyses that reference this entity

GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance

neuroscience | 2026-04-28 | 7 hypotheses Top: 0.808

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861

Microglial subtypes in neurodegeneration — friend vs foe

neurodegeneration | 2026-04-17 | 7 hypotheses Top: 0.685

What are the molecular signatures that distinguish protective vs. harmful microg

neurodegeneration | 2026-04-12 | 0 hypotheses

Synaptic pruning by microglia in early AD

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.703

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (9)

Multi-agent debates referencing this entity

Structured research brief for hypothesis h-var-e2b5a7e7db: GluN2B-Mediated Thala

active · Rounds: 4 · Score: 0.82 · 2026-04-28

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

closed · Rounds: 4 · Score: 0.64 · 2026-04-26

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key mechanistic, therapeutic, and diagnostic dimensions of TREM2 in

closed · Rounds: 4 · Score: 0.92 · 2026-04-26

The debate transcript shows incomplete information exchange, suggesting this fun

closed · Rounds: 4 · Score: 0.49 · 2026-04-18

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Synaptic pruning by microglia in early AD

closed · Rounds: 4 · Score: 0.95 · 2026-04-06

Related Research

Hypotheses and analyses mentioning CX3CL1 in their description or question text

No additional research found